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Simple Summary: The objective of this study was to investigate the role of two microenvironmental
factors, namely, tumor-intrinsic hypoxia and secretome in inducing collective migration. We utilized
three-dimensional (3D) discrete-sized microtumor models, which recapitulate hallmarks of transition
of ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC). Tumor-intrinsic hypoxia
induced directional migration in large hypoxic microtumors while secretome from large microtumors
induced radial migration in non-hypoxic microtumors. This highlights the emergence phenotypic
heterogeneity and plasticity in cancer cells in response to different microenvironmental stimuli. To
unravel mechanisms underlying these two distinct modes of migration, we performed differential
gene expression analysis of hypoxia- and secretome-induced migratory phenotypes using non-
migratory, non-hypoxic microtumors as controls. We proposed unique gene signature sets related
to tumor-intrinsic hypoxia, hypoxia-induced epithelial-mesenchymal transition (EMT), as well as
hypoxia-induced directional migration and secretome-induced radial migration.
Abstract: Collective cell migration is a key feature of transition of ductal carcinoma in situ (DCIS)
to invasive ductal carcinoma (IDC) among many other cancers, yet the microenvironmental factors
and underlying mechanisms that trigger collective migration remain poorly understood. Here, we
investigated two microenvironmental factors, tumor-intrinsic hypoxia and tumor-secreted factors
(secretome), as triggers of collective migration using three-dimensional (3D) discrete-sized micro-
tumor models that recapitulate hallmarks of DCIS-IDC transition. Interestingly, the two factors
induced two distinct modes of collective migration: directional and radial migration in the 3D micro-
tumors generated from the same breast cancer cell line model, T47D. Without external stimulus, large
(600 µm) T47D microtumors exhibited tumor-intrinsic hypoxia and directional migration, while small
(150 µm), non-hypoxic microtumors exhibited radial migration only when exposed to the secretome
of large microtumors. To investigate the mechanisms underlying hypoxia- and secretome-induced di-
rectional vs. radial migration modes, we performed differential gene expression analysis of hypoxia-
and secretome-induced migratory microtumors compared with non-hypoxic, non-migratory small
microtumors as controls. We propose unique gene signature sets related to tumor-intrinsic hypoxia,
hypoxia-induced epithelial-mesenchymal transition (EMT), as well as hypoxia-induced directional
migration and secretome-induced radial migration. Gene Set Enrichment Analysis (GSEA) and
protein-protein interaction (PPI) network analysis revealed enrichment and potential interaction
between hypoxia, EMT, and migration gene signatures for the hypoxia-induced directional migration.
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In contrast, hypoxia and EMT were not enriched in the secretome-induced radial migration, suggest-
ing that complete EMT may not be required for radial migration. Survival analysis identified unique
genes associated with low survival rate and poor prognosis in TCGA-breast invasive carcinoma
dataset from our tumor-intrinsic hypoxia gene signature (CXCR4, FOXO3, LDH, NDRG1), hypoxia-
induced EMT gene signature (EFEMP2, MGP), and directional migration gene signature (MAP3K3,
PI3K3R3). NOS3 was common between hypoxia and migration gene signature. Survival analysis
from secretome-induced radial migration identified ATM, KCNMA1 (hypoxia gene signature), and
KLF4, IFITM1, EFNA1, TGFBR1 (migration gene signature) to be associated with poor survival
rate. In conclusion, our unique 3D cultures with controlled microenvironments respond to different
microenvironmental factors, tumor-intrinsic hypoxia, and secretome by adopting distinct collective
migration modes and their gene expression analysis highlights the phenotypic heterogeneity and
plasticity of epithelial cancer cells.
Keywords: tumor microenvironment; tumor-intrinsic hypoxia; epithelial-mesenchymal transition
(EMT); collective migration; three-dimensional cultures; microtumors; microarray; bioinformatic analysis
1. Introduction
Approximately 1 in 5 of breast cancers detected through mammography are pre-
invasive ductal carcinoma in situ (DCIS) [1]. If left untreated, DCIS will progress to more
deadly invasive ductal carcinoma (IDC) [2]. Lack of mechanistic understanding on how
a pre-malignant breast cancer in situ develops into a malignant invasive breast cancer
contributes to a growing problem of inadequate clinical treatment. The existing evidence
that pre-invasive DCIS and IDC exhibit comparable genomic profiles [3,4] suggests that the
transition to an invasive breast cancer is driven by microenvironmental factors prevalent in
the pre-malignant phenotype, and not by genetic abnormalities in DCIS. Tumor-intrinsic hy-
poxia is one of the hallmarks of DCIS microenvironment, and is associated with phenotypic
changes that may lead to a more aggressive behavior [5].
Recently, IDC was shown to exhibit multicellular cohesive invasion, in which the
cells migrate collectively to invade the surrounding extracellular matrix (ECM) [6]. Such
collective migratory behavior is also observed in other aggressive cancers and has been
associated with invasion into surrounding tissue and distant metastasis [7,8]. Given that
tumor invasion and metastasis are the leading causes of cancer mortality [9], it is important
to understand the emergence of migratory phenotypes that contribute to poor clinical out-
comes. Collective migration in IDC is attributed to the conserved expression of E-cadherin
and other cell-cell junction molecules, along with the upregulation of mesenchymal mark-
ers observed in human tissue samples and mouse models of IDC [8]. Collectively migrating
cell groups exhibit different movement dynamics, which depend on the cell-ECM interac-
tions, cell adhesion systems, and the status of epithelial and mesenchymal markers in the
tumor cell population, all of which are influenced by the crosstalk between tumor cells and
surrounding microenvironment [10,11].
The tumor microenvironment plays an important role in emergence of aggressive
phenotypes [11]. Solid tumors including DCIS develop hypoxic microenvironment in
the core of the tumor away from the blood supply (hereafter tumor-intrinsic hypoxia)
due to lack of oxygen and nutrient supply [12,13]. Such hypoxic microenvironments
can activate intrinsic tumor signaling, which further initiates migratory events in cancer
cells [14–18]. Hypoxia can also induce tumor-secreted factors (secretome) that modify
the tumor microenvironment and act as extrinsic signaling to trigger a migratory and
invasive behavior [16,17,19]. Diversity reported in migration modes and mechanisms of
collective migration are dictated by the local tumor microenvironment [11,20]. However,
microenvironmental factors and underlying mechanisms that trigger collective migration
remain poorly understood.
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Given that microenvironmental factors such as hypoxia and secretome influence
the migratory behavior of cancer cells, it is important to develop an experimental sys-
tem that can reproducibly recapitulate the spontaneous emergence of tumor-intrinsic
hypoxic microenvironment along with tumor-secreted factors. Recently, different three-
dimensional (3D) in vitro models such as organoids, scaffold-based, and microfluidic mod-
els are being exploited to study the effect hypoxic microenvironment on tumor cells [21].
These models aim to recreate the hypoxic environment by external hypoxia using hypoxic
chambers [22,23], scaffolds with different thicknesses or densities to create oxygen gra-
dients [24,25], or by using external stimulus such as human stromal-cell derived factor-1
(SDF-1) gradient [26,27]. Culture of cancer cells in hypoxic chambers under reduced oxygen
tension cannot reproduce the spatial oxygen gradients and spatial heterogeneity observed
in solid tumors in vivo, where only an inner hypoxic core exists. This is because, in hy-
poxic chambers, all cells irrespective of their position are exposed to hypoxia, unlike what
is observed in vivo. Exposure to external stimulus like chemokines/cytokines although
recreates chemotaxis, it does not necessarily mimic global hypoxic environments. Thus,
these approaches fail to recreate the naturally formed, dynamic, tumor-intrinsic hypoxic
microenvironment observed in solid tumors.
To overcome this challenge, we engineered size-controlled 3D microtumor models in
which the microenvironment is solely defined by the microtumor size and tumor-secreted
factors [16,17,28–30]. In this system, we can recapitulate two different modes of collective
migration in response to two different microenvironmental factors: Tumor-intrinsic hypoxia
and secretome. This is achieved by reproducibly generating hundreds of uniform size,
small (150 µm) microtumors that are non-hypoxic and non-migratory, and large (600 µm)
microtumors that spontaneously develop tumor-intrinsic hypoxia without any external
stimulus, and exhibit directional migration [16,17,29]. The directional migratory phenotype
induced by tumor-intrinsic hypoxia was irreversible as cells from directionally migrating
tumors remained migratory even after being dissociated and regrown as non-hypoxic
small microtumors [16]. Notably, although hypoxia triggers directional migration, it does
not sustain the migratory phenotype since inhibition of hypoxia inducible factor 1 subunit
alpha (HIF1a) is effective in preventing migration only when the treatment is started at
early stages, and fail to prevent migration when the treatment is started at later stages [17].
We have also shown that the conditioned media (CM, secretome) of the large directionally
migrating tumors contain elevated levels of soluble E-cadherin (sE-CAD), Fibronectin (Fib),
and Matrix metalloproteinase-9 (MMP9) and induced migratory behavior in small non-
hypoxic and non-migratory microtumors [17]. Treatment with sE-CAD alone could induce
the migratory phenotype in non-migratory 150 µm microtumors. [17]. It should be noted
that both, the large directional and small radial migrating tumors moved collectively and
conserved the cell-cell junction markers E-cadherin (E-CAD) during the entire migratory
process [17], which is a key characteristic of collective migration [31,32].
The goal of this study is to investigate mRNA expression changes induced by tumor-
intrinsic hypoxia and secretome as two microenvironmental factors and elucidate the
plausible downstream mechanisms responsible for emergence of two distinct directional
and radial migratory phenotypes using our microtumor models with controlled microen-
vironments. Here, we analyzed the changes in gene expression profiles obtained by
microarray of these migratory microtumors compared to non-hypoxic and non-migratory
microtumors. In our approach, we identified differentially expressed genes (DEGs) in
tumor intrinsic hypoxia-induced directional migration (hereafter directional migration)
vs. non-hypoxic small tumors, and secretome-induced radial migration (hereafter radial
migration) also compared to non-hypoxic small tumors. To uncover the molecular mech-
anisms using DEGs, we performed bioinformatics analysis using multiple enrichment
analysis tools and identified enriched gene ontology (GO) terms and biological pathways.
We then constructed unique gene expression signature profiles for tumor-intrinsic hypoxia,
hypoxia-induced epithelial-mesenchymal transition (EMT), hypoxia-induced directional
migration, and secretome-induced radial migration, and evaluated the interaction between
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them. We performed survival analysis to evaluate the usefulness of the signature profiles
to be used as a prognosis tool.
2. Material and Methods
2.1. Cell Lines and Cell Culture
The breast cancer cell line (T47D) was purchased from American type culture collection
(ATCC). Cell culture supplies and media were obtained from Corning® and Mediatech®,
respectively, unless specified. The cells were passaged and maintained in T75 flasks in
Dulbecco’s modified Eagle’s medium (DMEM) (MT10013CV, Corning®, Lawrenceville, VA,
USA) supplemented with 10% fetal bovine serum (FBS) (S11250, Atlanta biologicals, Flower
Branch, GA, USA), and 1% penicillin-streptomycin (300-002-CI, Corning®, Christiansburg,
VA, USA) in a humidified atmosphere at 37 ◦C and 5% CO2. Cells were maintained
below 60% confluency for further seeding into hydrogel microwell devices. Cell line
authentication was done by University of Arizona, Genetics Core by using PowerPlex16HS
PCR Kit as previously described [17].
2.2. Microtumor Fabrication
Microtumors of 150 µm (referred to as ‘small’ microtumors) and 600 µm diameters
(referred to as ‘large’ microtumors) were obtained by seeding T47D cells in non-adhesive
polyethylene glycol (PEG) hydrogel microwell devices, as previously described [16,17,29,33].
Briefly, 1 × 1 cm2 microwell devices were fabricated using polydimethyl siloxane (PDMS)
stamps containing posts of either 150 µm or 600 µm in diameter with equal height. A
solution of 20% w/v polyethylene glycol dimethacrylate (PEGDMA, 1000Da, Polysciences,
Inc., USA) containing photoinitiator (Irgacure-1959, 1% w/v, Ciba AG CH-4002, Basel,
Switzerland) was crosslinked under the PDMS stamps using OmniCure S2000 curing
station (200W Lamp, 5 W/cm2, EXFO, Mississauga, ON, Canada). The microwell hydrogel
devices were sterilized by submerging in 70% ethanol under UV light for 1 h under laminar
air flow. Sterilized devices were then washed three times with Dulbecco’s phosphate
buffered saline (DPBS) without calcium and magnesium (Corning™, USA, catalog #21-
031-CV). For cell seeding, a suspension of 1.0 × 106 T47D cells (less than 15 passages) in
50 µL of growth media was dropped on each hydrogel microwell device and cells were
allowed to settle in the microwells for 15–30 min and those outside the microwells were
removed by gentle washing with DPBS. The cell-seeded devices were cultured at 37 ◦C and
5% CO2 in a humidified incubator. To study tumor migration due to tumor-intrinsic hy-
poxia, 600 µm microtumors were cultured for up to 6 days (referred to as 600D6 hereafter)
with replacement of 50% media with equal quantity of fresh media every day. To study
secretome-induced migration, 150 µm microtumors were treated with conditioned media
of 600 µm microtumors (denoted as ‘600/CM’) starting from day 3 to day 6 (referred to as
150CM hereafter), with replacement of 50% media with equal amount of 600/CM every
day as described earlier [17]. Small 150 µm microtumors that are shown to be non-hypoxic
and non-migratory were cultured similarly for 6 days with 50% fresh media change every
day (referred to as 150D6 hereafter) and used as non-hypoxic and non-migratory controls.
2.3. Microarrays and Bioinformatic Analysis
2.3.1. Microarrays
At the end of 6-day culture, RNA was isolated from 150D6, 600D6, and 150CM
microtumors using GenElute™ Mammalian Total RNA Miniprep Kit (Sigma-Aldrich, St.
Louis, MO, USA, cat #RTN70-1KT) and DNA cleanup was done by On-Column DNase I
Digestion Set (Sigma-Aldrich, St. Louis, MO, Cat#DNASE70-1SET) as per manufacturer’s
protocols. RNA quantity was measured by absorbance ratio at 260/280 nm and integrity
was verified on 1% agarose gel electrophoresis. cDNA preparation, hybridization to
GeneChips, scanning, and first-level data analysis were performed at the University of
Pittsburgh HSCRF Genomics Research Core as follows: Biotinylated cDNA was prepared
according to the standard Affymetrix Pico protocol from 5 ng total RNA (GeneChip Pico
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Reagent Kit User Guide, Rev. 4). Following fragmentation and labeling, 2.4 µg of cDNA
were hybridized for 16 h at 45 ◦C with 60 RPM rotation on GeneChip Clariom_S_Human
Genome Array. GeneChips were washed and stained on an Affymetrix Fluidics Station 450.
GeneChips were scanned using a GeneChip 3000 scanner with 7G upgrade and autoloader.
First level data analysis will be performed using Affymetrix Expression Console 1.2.0.20
using RMA_gene_full_signal normalization algorithm.
2.3.2. Bioinformatic Analysis
Microarray data is deposited in the Gene Expression Omnibus database at the National
Center for Biotechnology Information (GSE166211). The workflow of our bioinformatic
analysis is outlined in Scheme 1 and is described in detail as follows: Differential gene
expression in migratory 600D6 induced by tumor-intrinsic hypoxia or in 150CM induced
by secretome was analyzed by normalization with the 150D6 (groups 600D6 vs. 150D6 and
150CM vs. 150D6, respectively, Scheme 1).
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1. Identified differentially expressed genes (DEGs) in tumor-intrinsic hypoxia-induced
directional migration (600D6 vs. 150D6) and in secretome-induced radial migration
(150CM vs. 150D6) using TAC
Cancers 2021, 13, 1429 6 of 27
2. Identify statistically enriched Gene ontology biological processes and Hallmarks
associated with tumor-intrinsic hypoxia-induced directional migration and secretome-
induced radial migration using GSEA
3. Identify statistically enriched Gene ontology biological processes associated with
tumor-intrinsic hypoxia-induced directional migration and secretome-induced radial
migration using Correlation Engine
4. Identify statistically enriched pathways associated with tumor-intrinsic hypoxia-
induced directional migration and secretome-induced radial migration using Ingenu-
ity Pathway Analysis
5. Examine the enrichment of Hallmark hypoxia, GO EMT, and GO Tissue migration in
the DEGs of tumor-intrinsic hypoxia-induced directional migration and in secretome-
induced radial migration using GSEA
6. Examine the significance of correlation of DEGs in tumor-intrinsic hypoxia-induced
directional migration and secretome-induced radial migration with Go response to
hypoxia and GO regulation of cell migration using BaseSpace Correlation Engine
7. Compilation of resultant genes from GSEA and BaseSpace Correlation Engine to
obtain signature gene sets associated with tumor-intrinsic hypoxia, hypoxia-induced
EMT, hypoxia-induced directional migration, and secretome-induced radial migration
8. Analysis of protein-protein interactions of gene signature sets in directional migra-
tion (tumor-intrinsic hypoxia, hypoxia-induced EMT, hypoxia-induced directional
migration signature gene sets) and secretome-induced radial migration using Net-
workAnalyst
9. Identify statistically enriched pathways associated with the signature gene sets us-
ing KEGG
10. Survival analysis of genes in signature gene sets using SurvExpress and the human
protein atlas
2.3.3. Identification of Differentially Expressed Genes
Transcriptome Analysis Console (TAC 4.0, ThermoFisher Scientific, Waltham, MA,
USA) was used to perform statistical analysis on each comparison using one-way ANOVA.
The initial assessment of the microarray expression data was performed by hierarchical
clustering using a cut-off p-value of 0.01. All the genes with False Discovery Rate (FDR) ≤
0.05, p-value ≤ 0.05 and fold change ± 2 were considered significantly different in terms of
gene expression and were selected for further analysis (Step 1). Volcano plots highlighting
differentially expressed genes (DEGs) were reconstructed using Bioconductor v3.9 in R [34].
2.3.4. Statistical Enrichment Analysis
A global analysis of the DEGs was carried out by gene ontology enrichment, hallmark
enrichment, and pathway enrichment analysis. Gene set enrichment analysis (GSEA) of
gene ontology and hallmarks was performed using the GSEA software (UC San Diego and
Broad Institute, San Diego, CA, USA) (Step 2). The gene ontology gene sets in GSEA are
part of the molecular signatures database (MSigDB) collections and contain 14750 gene sets
containing genes annotated by the same ontology term. This gene ontology sets are divided
into three components: biological processes (BP), cellular component (CC), or molecular
function (MF). Here, we focused on BP gene sets. The gene functional classification of BP
was carried out using DAVID bioinformatic database (DAVID Bioinformatics resources 6.8,
NIAID/NIH) (https://david.ncifcrf.gov/ accessed on 3 March 2021). Hallmark gene sets
are also part of MSigDB collections and comprise 50 gene sets that represent well-defined
biological processes. Gene ontology BP and Hallmark gene set enrichment (minimum size
cut off = 5) were carried out using a pre-ranked list based on fold change mapped with the
MSigDB human symbol v7.1 platform [35–37].
To perform a more comprehensive statistical enrichment, we repeated the gene on-
tology enrichment of BP using BaseSpace Correlation Engine (CE) (Illumina v2.0, USA)
(Step 3).
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Pathway enrichment analysis was performed using the Ingenuity Pathway Analy-
sis (IPA) suite of tools v01-16 (QIAGEN Digital Insights, Redwood City, CA, USA) to
identify the canonical pathways that are enriched and differentially regulated due to
tumor-intrinsic hypoxia and secretome as microenvironmental factors inducing collective
migration (Step 4). The list of DEGs between migratory 600D6 induced by tumor-intrinsic
hypoxia or in 150CM induced by secretome vs. non-hypoxic, non-migratory tumors was
uploaded, and the core analysis was performed in IPA using Clariom S human array as a
reference set. Significant differentially regulated canonical pathways were identified with a
threshold −log10 (p-value) of >1.3 using right-tailed Fisher Exact Probability Tests. By cal-
culating the z-scores, we determined the activity status of each pathway. The z-score gives
a statistical measurement of the gene expression pattern in the dataset for each pathway
compared to the expected pattern of expression based on literature [38].
A focused analysis was performed to investigate the role of genes related to tumor in-
trinsic hypoxia, EMT, and migration in the directional and radial migration patterns. GSEA
was used to obtain the enrichment score of ‘hallmark hypoxia’, and the gene ontology terms
‘epithelial to mesenchymal transition’, and ‘tissue migration’ in DEGs from directional
migratory tumors, and radial migratory tumors (Step 5). CE was used to analyze the
significance of association of DEGs from directional and radial migration groups with BP
such as ‘Response to hypoxia’ and ‘Regulation of cell migration’ from MSigDB.
2.3.5. Meta-Analysis
A meta-analysis was carried out to validate our results with the ones in other studies
that correlated genomic changes with hypoxic events. For this purpose, we used the meta-
analysis tool in CE to correlate the highly regulated genes in our study groups with the ones
found in seven publicly available studies (GSE3893 [39], GSE19123 [40], GSE29406 [41],
GSE70805 [42,43], GSE47533 [44], GSE9649 [45,46], and GSE30019 [47]) that studied the
effect of hypoxia in the gene expression of breast cancer cell lines or breast cancer tissue
(Supplementary Table S1) (Step 6).
2.3.6. Signature Gene Sets
Hypoxia, EMT, and migration-related genes from the previous GSEA and CE analysis
were extracted and grouped in unique signature gene sets, namely ‘Tumor-intrinsic hy-
poxia’, ‘Hypoxia-induced EMT’, ‘Hypoxia-induced directional migration’, and ‘Secretome-
induced radial migration’ signature gene sets (Step 7).
2.3.7. Protein-Protein Interaction Networks
Signature gene sets related to each directional and radial migratory tumors were
combined and used to generate the minimum protein-protein interaction (PPIs) networks
based on the InnateDB Interactome [48] using NetworkAnalyst v3.0 [49] (Step 8). Visual-
ization of PPIs was done in Cytoscape v3.7.2 [50]. One of the features of NetworkAnalyst
is the possibility to perform functional analysis of the constructed PPI network. Then the
Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment was done using
the genes participating in the minimum PPI network directly in NetworkAnalyst using a
statistical significance of p-value < 0.05 (Step 9).
2.3.8. Survival Analysis
Survival analysis of signature genes related to tumor-intrinsic hypoxia, hypoxia-
induced EMT, as well as hypoxia-induced directional migration and secretome-induced radial
migration (n = 174) was carried out using The Cancer Genome Atlas (TCGA) [51] breast
invasive carcinoma dataset in SurvExpress [52,53]. All 174 genes were analyzed for Cox
survival analysis using ‘breast’ tissue, and ‘BRCA-TCGA’ breast invasive carcinoma dataset
with 962 patients and censored for survival days in the software. Similarly, protein expression
analysis was performed using The Human Protein Atlas (HPA) [54–56] for hypoxia, EMT,
and directional and radial migration signature genes, which were able to significantly predict
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survival in invasive breast cancer patients. Corresponding protein expression analysis by
immunohistochemistry was presented for normal and breast cancer tissues (Step 10).
3. Results
3.1. Three-Dimensional Microtumor Models Exhibit Two Distinct Modes of Collective Migration
in Response to Different Microenvironmental Factors: Tumor-Intrinsic Hypoxia and Secretome
We engineered discrete-sized 3D microtumor models to recapitulate DCIS-IDC transi-
tion [16,17,29], which exhibit distinct modes of collective migration, namely, directional and
radial migration in response to two different microenvironmental stimuli, tumor-intrinsic
hypoxia and tumor-secreted factors or ‘secretome’, respectively (Figure 1). In our system,
we can reproducibly generate two distinct phenotypes from the same non-invasive parent
T47D breast cancer cells, namely, small (150 µm) non-hypoxic, non-migratory microtumors,
and large (600 µm) migratory microtumors that develop intrinsic hypoxia (Figure 1A,B).
Our results demonstrate that large hypoxic microtumors exhibit directional collective mi-
gration starting from day 3 in culture with almost total migration of the tumors outside the
microwells by day 6 (600D6). In contrast, small microtumors remain non-migratory in the
microwells from day 1 to day 6 (150D6) (Figure 1B). When treated with conditioned media
(CM) from large hypoxic (600 µm) microtumors, small microtumors (150CM) exhibit non-
directional, radial collective migration (Figure 1C). Here, we analyzed the changes in gene
expression obtained by microarray to understand the genomic differences in spontaneous
emergence of these two distinct, directional and radial migratory phenotypes induced in
3D T47D microtumors by tumor-intrinsic hypoxia (600D6) and secretome (150CM), respec-
tively. We used non-hypoxic, non-migratory microtumors (150D6) as controls (Figure 1D).
Cancers 2021, 13, x FOR PEER REVIEW 9 of 27 
 
 
Figure 1. 3D models of breast cancer recapitulate two distinct modes of collective migration due to 
different microenvironmental factors: tumor intrinsic hypoxia and secretome. (A) Schematic repre-
sentation of our 3D hydrogel microwell system in which we can generate small (150 µm) and large 
(600 µm) microtumors. (B) Small microtumors are non-hypoxic and non-migratory, whereas large 
microtumors develop size-related intrinsic hypoxia and migrate directionally. (C) We can induce 
radial migration by treating the small non-hypoxic non-migratory tumors with the secretome of 
large hypoxic directional migrating tumors. (D) We performed bioinformatic analysis of microarray 
data to study the changes in gene expression of large hypoxic directional migrating microtumors 
and small non-hypoxic radially migrating microtumors compared to non-hypoxic and non-migra-
tory microtumors. 
3.2. Global Changes in Gene Expression Induced by Tumor-Intrinsic Hypoxia and Secretome 
3.2.1. Differentially Expressed Genes 
Hierarchical clustering of gene expression data showed that independent biological 
replicates for each of the microtumor groups (600D6, 150CM, and 150D6) clustered to-
gether, demonstrating the reliability of our 3D microwell system to generate independent 
and consistent gene expression profiles. Experimental groups with similar size micro-
tumors, namely 150D6 and 150CM, clustered in the first level followed by large micro-
tumors (600D6), indicating more changes in gene expression of 600D6 induced by tumor-
intrinsic hypoxia compared to those induced by secretome in 150CM microtumors (Sup-
plementary Figure S1). Using a comparative gene expression analysis, we identified 1992 
differentially expressed genes (DEGs) in the directionally migrating microtumors (600D6 
vs. 150D6) induced by tumor-intrinsic hypoxia, which include 734 upregulated genes and 
1258 downregulated genes. We also identified 305 DEGs in the radially migrating micro-
tumors (150CM vs. 150D6) induced by secretome, of which 189 genes were upregulated 
and 116 genes were downregulated. Volcano plots of genes based on intensity values 
showed that tumor-intrinsic hypoxia had a greater effect on modulating gene expression 
compared to the secretome (Figure 2A). 
i re 1. 3D models of breast cancer recapitulate two distinct m des of collective migration due
to different microenvironmental factors: tumor intrinsic hypoxia and secretome. (A) Schematic
representation of our 3D hydrogel microwell system in which we can generate small (150 µm) and
large (600 µm) microtumors. (B) Small microtumors are non-hypoxic and non-migratory, whereas
large microtumors d velop size-related intrinsi hypoxia and migrate directionally. (C) We can
induce radial migration by treating the small non-hypoxic no -migratory tum rs with the secre-
tome of large hypoxic directional migrating tumors. (D) We performed bioinfor atic analysis of
microarray data to study the changes in gene expression of large hypoxic directional migrating
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3.2. Global Changes in Gene Expression Induced by Tumor-Intrinsic Hypoxia and Secretome
3.2.1. Differentially Expressed Genes
Hierarchical clustering of gene expression data showed that independent biological
replicates for each of the microtumor groups (600D6, 150CM, and 150D6) clustered together,
demonstrating the reliability of our 3D microwell system to generate independent and
consistent gene expression profiles. Experimental groups with similar size microtumors,
namely 150D6 and 150CM, clustered in the first level followed by large microtumors
(600D6), indicating more changes in gene expression of 600D6 induced by tumor-intrinsic
hypoxia compared to those induced by secretome in 150CM microtumors (Supplementary
Figure S1). Using a comparative gene expression analysis, we identified 1992 differentially
expressed genes (DEGs) in the directionally migrating microtumors (600D6 vs. 150D6)
induced by tumor-intrinsic hypoxia, which include 734 upregulated genes and 1258 down-
regulated genes. We also identified 305 DEGs in the radially migrating microtumors
(150CM vs. 150D6) induced by secretome, of which 189 genes were upregulated and
116 genes were downregulated. Volcano plots of genes based on intensity values showed
that tumor-intrinsic hypoxia had a greater effect on modulating gene expression compared
to the secretome (Figure 2A).
3.2.2. Gene Ontology and Pathway Enrichment Analysis
We performed a comprehensive statistical enrichment of GO: BP in directional mi-
gration and radial migration (Figure 2B). GSEA GO terms that showed opposite direction
of enrichment mostly coded for the cell-cell interaction, ECM components, cytoskele-
tal and actin filament organization, tumor-secreted factors and response to stress. In
tumor-intrinsic hypoxia (600D6); ‘positive regulation of locomotion’ was the most enriched
biological process followed by ‘sensory perception’, ‘cell activation’, ‘cell-cell adhesion’,
and ‘cellular response to toxic substance’ (Figure 2B(i)). While these adhesion-related
processes were upregulated in hypoxic directional migration, they were downregulated
in secretome-induced radial migration, highlighting role of cell adhesion and cell junc-
tion organization in hypoxia-induced directional migration in large microtumors. In the
secretome-induced radial migration (150CM), the GO terms related to cytoskeletal and
actin filament organization, response to type-1 interferon were enriched and upregulated
(Figure 2B(ii)) in contrast to the hypoxia-induced directional migration, suggesting signifi-
cance of cytoskeletal organization in radial migration.
Using GSEA hallmark analysis, we identified upregulated and downregulated hall-
mark gene sets (Figure 2C) enriched in the hypoxia-induced and secretome-induced mi-
gratory microtumors. We identified 21 upregulated and 15 downregulated hallmarks in
the hypoxia-induced directional migration. In this group, the top upregulated hallmark
gene set was ‘Hypoxia’ while the top downregulated gene set was ‘G2M checkpoint’.
In secretome-induced radial migration, only two hallmark gene sets were enriched and
upregulated, namely, ‘TNFα signaling via NF-κB’, and ‘mTORC1 signaling’.
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Figure 2. Global changes in gene expression caused by tumor-intrinsic hypoxia and secretome. (A) Volcano plots show-
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migration (left) and secretome-induced radial migration (right) using a False Discovery Rate (FDR) ≤ 0.05, p-value ≤
0.05, and fold change ± 2. (B) GSEA analysis showing upregulated (red) and downregulated (green) hallmarks for B(i)
hypoxia-induced directional migration and B(ii) secretome-induced radial migration using minimum size cut off = 5.
(C) Gene ontology (GO) analysis showing oppositely regulated biological processes: C(i) upregulated (red) in tumor-
intrinsic hypoxia-induced directional migration, and downregulated (green) in secretome-induced radial migration and
C(ii) downregulated (green) in tumor-intrinsic hypoxia-induced directional migration and upregulated (red) in secretome-
induced radial migration. (D) Ingenuity Pathway Analysis (IPA) enriched and differentially regulated due to tumor-intrinsic
hypoxia and secretome. Upregulated pathways are shown in red and downregulated in green. The differentially regulated
canonical pathways were identified with a threshold –log10 (p-value) of >1.3.
The ingenuity pathway analysis (IPA) software was used to perform statistical enrich-
ment analysis of molecular pathways. A total of 111 canonical pathways were upregulated
while 204 pathways were downregulated in hypoxia-induced directional migration. Of
these, ‘sirtuin signaling pathway’, ‘cell cycle: G2/M DNA damage checkpoint regula-
tion’, ‘senescence pathway’, ‘unfolded protein response’, and ‘p53 signaling’ were top five
upregulated pathways, whereas ‘cell cycle control of chromosomal replication’, ‘super-
pathway of cholesterol biosynthesis’, ‘aryl hydrocarbon receptor signaling’, ‘cholesterol
biosynthesis I’, and ‘cholesterol biosynthesis II’ were top five downregulated pathways
(Supplementary Figure S2). In secretome-induced radial migration, 49 pathways were
upregulated, and 23 pathways were downregulated. Of these, ‘unfolded protein response’,
‘interferon signaling’, ‘superpathway of cholesterol biosynthesis’, ‘BAG2 signaling path-
way’, ‘Wnt/β-catenin signaling’ were the topmost upregulated while ‘senescence pathway’,
‘ATM signaling’, ‘role of BRCA1 in DNA damage response’, ‘role of CHK proteins in cell
cycle checkpoint control’ and ‘p53 signaling’ were top five downregulated pathways (Sup-
plementary Figure S2). We then evaluated the oppositely regulated pathways, which
may drive different migration phenotypes observed in directional migration and radial
migration. As expected, ‘HIF1α signaling’ is significantly upregulated in directional migra-
tion and downregulated in radial migration (Figure 2D). In hypoxia-induced directional
migration, ‘role of CHK proteins in cell cycle checkpoint control’, ‘p53 signaling’, ‘senes-
cence pathway’ and ‘sirtuin signaling pathway’ were significantly upregulated while the
‘sphingosine-1-phosphate signaling’, ‘estrogen receptor signaling’ and ‘superpathway of
cholesterol biosynthesis’ were downregulated. In the secretome-induced radial migration,
these pathways were oppositely regulated in addition to the significant upregulation of
‘interferon signaling’ and downregulation of ‘T cell exhaustion signaling pathway’ and
‘p38 MAPK signaling’.
3.3. Hypoxia Is Enriched Only in Large Microtumors with Directional Migration
To examine the influence of hypoxia in the directional and radial migration observed
in our two microtumor models (600D6 and 150CM, respectively), we used Correlation
Engine (CE) to obtain significance of correlation of our gene expression data with gene
ontology (GO) term ‘response to hypoxia’ (Figure 3A,B) and GSEA to obtain enrichment
score for ‘hallmark hypoxia’ gene set (Figure 3C). The rationale for using both GSEA
and CE is the difference in the statistical algorithm used by each software to perform the
enrichment. GSEA implements a running-sum statistic to calculate the enrichment score
(ES) and uses empirical phenotype-based permutations to estimate significance [35]. CE
uses a running fisher algorithm analogous to GSEA that calculates a correlation score.
However, the statistical significance is estimated by a Fisher’s exact test rather than by
permutations [57]. CE results indicated that 221 genes belong to ‘response to hypoxia’
GO term, of which 33 genes (14.9%) were common with the DEGs in the directional
migration, while only 8 genes (3.6%) were common with the DEGs in the radial migration
(Figure 3A,B). The p-value of overlap with ‘response to hypoxia’ was 8 orders of magnitude
higher in the directional migration compared to radial migration (p = 1.6 × 10−12 and 4 ×
10−4, respectively) (Figure 3B). GSEA results demonstrated that ‘hallmark hypoxia’ gene
set collection with 200 genes [58] is enriched only in directional migration (NES = 4.19,
Figure 3C). From the results in CE and GSEA, we then extracted and compiled the genes
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in ‘response to hypoxia’ biological process, and hallmark ‘hypoxia’ that are common
to the DEGs in each, the directional and radial migration phenotypes. These group of
genes are denoted hereafter as 79-gene tumor-intrinsic hypoxia signature and 8-gene
secretome-induced hypoxia signature, respectively. For directional migration, out of 79-
gene tumor-intrinsic hypoxia signature, 46 genes belong exclusively to GSEA, 24 genes
to CE, and 9 genes were common between GSEA and CE. In secretome-induced radial
migration, the hypoxia signature consists of only 8 genes that overlapped with ‘response to
hypoxia’ in CE. We speculate that adding hypoxic secretome to non-hypoxic tumors can
induce gene expression changes that fall under the term ‘response to hypoxia’ despite the
fact the radially migrating small tumors do not develop intrinsic hypoxia. In a further CE
meta-analysis, we obtained the significance of overlap with GO term ‘response to hypoxia’
for seven publicly available genomic studies (Supplementary Table S1) that examined
the gene expression changes in breast cancer tissue or cell lines in response to hypoxic
conditions. We further validated our results obtained for tumor-intrinsic hypoxia, and
secretome-induced hypoxia gene signatures by comparing with these publicly available
datasets (Figure 3D). The p-value of overlap in hypoxia-induced directional migration
model with the term ‘response to hypoxia’ (p = 1.6 × 10−12) was comparable with other
reported studies comparing invasive tumors with ductal carcinoma in situ (GSE3893,
p = 4.9 × 10−12), MCF7 cells exposed to 4 h hypoxia (GSE19123, p = 1.7 × 10−11), or 24 h
hypoxia (GSE70805, p = 4.7 × 10−14), or 48 h hypoxia (GSE47533, p = 9.30 × 10−16) or
24 h hypoxia and lactate (GSE29406, p = 2.2 × 10−10) (Supplementary Table S1). On the
other hand, the significance of overlap of secretome-induced radial migration with the
term ‘response to hypoxia’ (p = 4 × 10−4) is considerably lower than that obtained for studies
GSE3893, GSE19123, GSE29406, GSE70805, and GSE47533 (Supplementary Table S1). The
expression profile of the genes related to ‘response to hypoxia’ in our hypoxia- and secretome-
induced migration models was negatively correlated to the ones in studies GSE9649 and
GSE30019 (Supplementary Table S1), which was expected. This is because these studies
compared the genomic changes of human breast cancer cell monolayers cultured in hypoxic
conditions with lactic acidosis and re-oxygenation respectively, which may cause different
signaling events when compared to our study, where we analyzed hypoxic vs. non-hypoxic
conditions in 3D cultures.
Figure 3E,F show heatmaps of the genes associated with the hypoxia gene signatures
of each migratory phenotype, displaying a high level of expression in red and a low level
of expression in blue.
There were only three genes common between the hypoxia gene signatures of the
two comparisons (Figure 3G). ADM was upregulated in both groups. However, ATM
and KCNMA1 were upregulated in directional migration and downregulated in radial
migration. We experimentally confirmed that the directionally migrating tumors develop
intrinsic hypoxia (Figure 3H(i)) while secretome-treated small radially migrating microtu-
mors develop none to little hypoxia (Figure 3H(ii)) using Ru-dpp-based hypoxia stain [16],
further validating our microarray analysis.
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term, as well as the 8 common genes between secretome-induced radial migration and ‘response to
hypoxia’ GO term. (B) Significance of overlap (p-value and % of overlap) of differentially expressed
genes (DEGs) in tumor intrinsic hypoxia-induced directional migration and secretome-induced radial
migration with ‘response to hypoxia’ GO term. (C) GSEA enrichment plot of DEGs showing 55
genes enriched in tumor intrinsic hypoxia-induced directional migration out of 87 in ‘Hallmark
hypoxia’ and a Normalized Enrichment Score (NES) of 4.19. (D) Correlation Engine meta-analysis,
comparing the significance of overlap with the GO term ‘response to hypoxia’ of hypoxia-induced
directional migration, secretome-induced radial migration, and seven publicly available genomic
studies (GSE3893, GSE19123, GSE29406, GSE70805, GSE47533, GSE9649, GSE30019) that examined
the gene expression changes in breast cancer tissue or cell lines in response to hypoxic conditions
(details in Supplementary Table S1). (E) Heat map of tumor-intrinsic hypoxia 79-gene signature
set that compiles genes in ‘response to hypoxia’ GO term, and ’hallmark hypoxia’ common to the
DEGs in the directional migration. (F) Heat map of radial migration hypoxia 8-gene signature set
that compiles genes in ’response to hypoxia’ GO term common to the DEGs in the radial migration.
(G) Venn diagram displaying the 3 common genes between directional migration tumor intrinsic
hypoxia 79-gene signature set and radial migration hypoxia 8-gene signature set. (H) Hypoxic
stain with Ru-dpp of H(i) hypoxic directionally migrating tumors, and H(ii) secretome-treated non-
hypoxic radially migratory tumors. Yellow dashed circular outline delineates the microwell. White
arrows indicate the direction of migration.
3.4. Tumor-Intrinsic Hypoxia Induces Epithelial-Mesenchymal Transition (EMT)
We then sought to delineate the contribution of epithelial mesenchymal transition
(EMT) to induce the observed modes of directional and radial migration in response to
tumor-intrinsic hypoxia and secretome, respectively. We obtained enrichment scores for
GSEA hallmark ‘epithelial to mesenchymal transition (EMT)’ for DEGs in both migratory
phenotypes. Hallmark ‘EMT’ was enriched only in the large microtumors showing tumor-
intrinsic hypoxia and directional migration (NES = 2.32, Figure 4A) and was not enriched
in small non-hypoxic microtumors that exhibit secretome-induced radial migration. In
the directional migratory phenotype, 26 genes (13%) overlapped with the hallmark EMT
gene set. These genes are hereafter denoted as tumor-intrinsic hypoxia-induced 26-gene
EMT signature.
The heatmaps of the genes associated with the EMT gene signature of directional
migration are shown in Figure 4B, displaying a high level of expression in red and a low
level of expression in blue. We further performed the meta-analysis of hypoxia-induced
26-gene EMT signature from directional migratory phenotype with publicly available
gene expression datasets similar to Section 3.3 (Supplementary Table S1, Figure 4C). The
p-value of overlap of tumor-intrinsic hypoxia-induced EMT gene signature was highest
with GSE3893 (p = 2.4 × 10−27) comparing invasive vs. ductal breast carcinoma, followed
by GSE29406 (p = 9.52.4 × 10−6) and GSE47533 (p = 6.2 × 10−7) where MCF-7 cells were
treated under hypoxic conditions. Positive correlation was also observed with datasets from
studies GSE19123 (p = 0.073) and GSE70805 (p = 0.0373) where MCF-7 cells were grown in
hypoxic conditions for 4 h and 24 h, respectively, and compared with cells cultured under
normoxia. This suggests that the proposed tumor-intrinsic hypoxia-induced 26-gene EMT
signature is enriched in large hypoxic microtumors with directional migration. Similar to
results from Section 3.3, EMT gene signature negatively correlated with gene expression
data from studies GSE9649 (p = 4.6 × 10−5), and GSE30019 (p = 0.0149) (Figure 4C).
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3.5. The Process of Migration Is Enriched Equally in Both Directional and Radial
Migratory Phenotypes
To determine if the process of migration is enriched in both the directional and radial
migratory phenotypes, we examined the significance of correlation of the DEGs with the
GO term ‘regulation of cell migration’ from CE and enrichment score for ‘tissue migration’
gene set from GSEA. Out of 375 genes that belong to the ‘regulation of cell migration’ GO
term, 40 genes (10.6%) overlapped with DEGs in the directional migration, while 14
(3.7%) overlapped with the DEGs in the radial migration (Figure 5A). Despite a higher
percentage of overlap in the directional migration compared to radial migration, the p-
value of overlap was comparable between the two groups (4.1 × 10−9 and 7.0 × 10−7,
respectively) (Figure 5B). Moreover, GSEA enrichment scores for both directional and radial
migration showed similar NES for the ‘tissue migration’ gene set (1.724 vs. 1.721 respectively,
Figure 5C). We also performed a CE meta-analysis to obtain the significance of overlap with
‘regulation of cell migration’ GO term of the seven publicly available genomic studies that we
previously used (Supplementary Table S1). Figure 5D shows the comparison of these results
with the significance of overlap obtained for directional and radial migration phenotypes
with ‘regulation of cell migration’. The p-value of overlap for the directional migration
with ‘regulation of cell migration’ (p = 4.10 × 10−9) was comparable with studies where
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MCF7 cells were cultured under 24 h hypoxia (GSE70805, p = 4.7 × 10−8), 48 h hypoxia
(GSE47533, p = 2.2 × 10−9), and 24 h hypoxia and lactate (GSE29406, p = 4.6 × 10−11).
The significance of overlap for radial migration with ‘regulation of cell migration’ (p = 3.6 ×
10−6) was also comparable with the studies GSE29406, GSE70805, and GSE9649 (p = 2 ×
10−4) (Supplementary Table S1). We note that the expression profile of the genes related to
‘regulation of cell migration’ in hypoxia- and secretome-induced distinct migration modes
was negatively correlated to that in study GSE30019 (Supplementary Table S1)), which
analyzed gene expression of MCF7 cells exposed to 24 h hypoxia vs. 12 h re-oxygenation,
indicating that re-oxygenated cells downregulate genes related to cell migration.
Similar to Sections 3.3 and 3.4, we compiled the common genes between each of our
hypoxia- and secretome-induced migration and both the ‘regulation of cell migration’
GO term from CE and ‘tissue migration’ gene set from GSEA (Figure 5E). The compiled
migration related genes for each group are denoted hereafter as 69-gene directional mi-
gration signature and 21-gene radial migration signature (Figure 5E,F). Out of 69-gene
directional migration signature, 30 genes are derived from GSEA, 27 genes are derived
from CE and 12 genes are common between GSEA and CE. The secretome-induced radial
migration gene signature consists of 21 genes, of which 7 genes are extracted from GSEA,
11 genes are from CE, and 3 genes are common between GSEA and CE. We identified
only 6 genes that were common to both directional and radial migration signature gene
sets (Figure 5G). Genes EFNA1, KLF4, and JUN were upregulated while TGFBR1 was
downregulated in both directional and radial migration. On the other hand, AKT2 and
IFITM1 were downregulated in directional migration and upregulated in radial migration.
3.6. Directional and Radial Migration Modes Emerge from Different Molecular Drivers with
Distinct PPIs That Participate in the Same Migration-Related Pathways
We then set out to understand how directional and radial migration modes are driven
by tumor-intrinsic hypoxia and secretome. We first analyzed 79-gene tumor-intrinsic
hypoxia, 26-gene EMT, and 69-gene directional migration signatures to establish how
tumor-intrinsic hypoxia drives directional migration through EMT. The functional classi-
fication of biological processes coding for tumor-intrinsic hypoxia, EMT, and migration
signature sets in both, the directional and radial migrating microtumors is presented in
Supplementary Table S2. In tumor-intrinsic hypoxia-induced migration, out of the hypoxia
(Figure 3E), EMT (Figure 4C), and directional migration gene signatures (Figure 5E), eight
genes were common between hypoxia and EMT gene signatures (TNFAIP3, VEGFA, JUN,
LOX, TGFBI, PLOD2, CXCL12, THBS1), 12 genes were common between hypoxia and mi-
gration signatures (VEGFA, JUN, NOS3, EFNA1, PRKCA, SIRT1, THBS1, CITED2, CXCL12,
SMAD3, CXCR4 and ICAM1), and eight genes were common between EMT and migration
gene signatures (VEGFA, JUN, PFN2, ECM1, LRP1, TIMP1, CXCL12, and THBS1). Of the
hypoxia, EMT, and migration gene signatures, four genes (VEGFA, JUN, CXCL12, THBS1)
were common among all three signatures (Figure 6A). Similarly, in secretome-induced
migration, two genes were common between the hypoxia and migration gene signatures
(LMNA and TGFBR3) (Figure 6D).
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Figure 5. Migration is equally enriched in both large and small migratory tumors displaying different patterns of migration.
(A) Venn diagram of correlation engine analysis showing the 40 common genes between tumor intrinsic hypoxia-induced
directional migration and ‘regulation of cell migration’ gene ontology (GO) term, as well as the 14 common genes between
secretom -i uced radial migratio and ‘regulation of cell migration’ GO term. (B) Sig ificance of overlap (p-value and
% of overlap) of differentially expressed genes (DEGs) in hypoxia-induced directional migration and secretome-induced
radial migration with ‘regulation of cell migration’ GO term. (C) GSEA enrichment plot of DEGs in GO ‘tissue migration’
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showing C (i) 42 genes enriched in hypoxia-induced directional migration out of 374 in ‘GO tissue migration’ and a
Normalized Enrichment Score (NES) of 1.724, and C (ii) 10 genes enriched in secretome-induced radial migration out of
374 in GO ‘tissue migration’ and a Normalized Enrichment Score (NES) of 1.721 (D) Correlation engine meta-analysis,
comparing the significance of overlap with the GO term ‘regulation of cell migration’ of hypoxia-induced directional migra-
tion, secretome-induced redial migration, and seven publicly available genomic studies(GSE3893, GSE19123, GSE29406,
GSE70805, GSE47533, GSE9649, GSE30019). (E) Heat map of 69-gene directional migration signature set that compiles genes
in ‘regulation of cell migration’ GO term, and ‘GO tissue migration’ that are common to the DEGs in hypoxia-induced
directional migration. (F) Heat map of 21-gene radial migration signature set that compiles genes in ‘regulation of cell
migration’ GO term, and ‘GO tissue migration’ that are common to the DEGs in in the secretome-induced radial migration.
(G) Venn diagram displaying the 6 common genes between the 69-gene directional migration signature set and the 21-gene
radial migration signature set.
We then constructed the PPI networks combining the hypoxia, EMT, and migration
signatures from directional migration (Figure 6B) and between hypoxia and migration
signatures in radial migration (Figure 6E). The directionally migrating tumors displayed
a zero-order network consisting of seed genes that have direct interaction without inter-
mediate nodes (Figure 6B). This network of directly interacting genes consisted of a total
of 36 genes, of which 15 genes belonged to the 79-gene tumor-intrinsic hypoxia signature,
2 genes belonged to the 26-gene hypoxia-induced EMT signature, and 8 genes belonged
to the 69-gene directional migration signature. The PPI network for directional migration
also displayed 7 genes common between hypoxia and directional migration signatures,
and 4 genes were common between hypoxia, EMT, and directional migration signatures
(VEGFA, JUN, CXCL12, THBS1). In case of radial migration, the minimum interaction net-
work consisted of 47 genes, of which 6 genes belonged to the secretome-induced hypoxia
signature and 19 genes belonged to the radial migration signature. The PPI network for
radial migration also displayed 2 genes (TGFBR3, LMNA) common between hypoxia and
radial migration, and 16 genes were intermediate genes added to connect the seed genes
(Figure 6E).
These results emphasize that there is no direct protein-protein interaction (PPI) be-
tween the hypoxia and migration signature genes in the radial migratory phenotype,
further confirming that this phenotype may not be directly driven by hypoxia. We then
obtained the clustering coefficient and network heterogeneity parameters to evaluate the
connectivity of each network using the NetworkAnalyzer tool from Cytoscape [59]. The
PPI between the tumor-intrinsic hypoxia and directional migration signature genes showed
higher clustering coefficient (0.13) than radial migration signature (0.013), and higher net-
work heterogeneity (0.8 vs. 0.08, respectively) indicating higher connectivity between the
nodes in the network and overall influence of the proteins in the network. KEGG pathway
analysis was performed on the minimum and first-order interaction networks (Figure 6B,
Supplementary Data S1) and revealed that the pathways enriched in PPIs in both the
directional and radial migration were similar even though the networks were built from
different genes (Figure 6C,F). From both the minimum and first order interaction networks,
we identified migration-related pathways such as FOXO signaling pathway, PI3K-AKT
signaling pathway, and focal adhesions, in both groups. Surprisingly, the hypoxia-related
HIF-1 signaling pathway was enriched in both groups. However, HIF-1 signaling was one
of the more enriched pathways in minimum network of directional migration with a higher
enrichment p-value (p = 1.71 × 10−19 vs. 3.5 × 10−3) and higher number of genes (25 vs.
2) compared to radial migration. We also identified the genes with high connectivity and
with more participation in the enriched pathways (Figure 6C,F, Supplementary Figure S3,
Supplementary Data S1). In directional migration, MAPK1, MAPK3, AKT1, AKT2, PIK3R2,
PIK3R3, EGFR, VEGFA, IKBKB, PRKCA, GRB2, MAPK8, KRAS, and PDGFRB (cut off ≥ 5)
showed the highest connectivity and most participation in the KEGG pathways (Figure 6C,
Supplementary Figure S3). In case of radial migration, JUN, ATM, NR4A1, and TGFBR1
are the genes with more connectivity while JUN, AKT2, and TGFBR1 showed more par-
ticipation in the enriched pathways (Figure 6F, Supplementary Figure S3, Supplementary
Data S1).
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only between the hypoxia and migration signature gene sets, 4 genes common only between hypoxia
and EMT, 4 genes common only between migration and EMT, and 4 common genes shared by hypoxia,
migration and EMT. The heat map displays the expression of the 4 common genes in the intersection
between hypoxia, migration, and EMT in the directional migration compared with non-hypoxic,
non-migratory tumors. (B) Zero-order protein-protein interaction (PPI) network combining the
hypoxia, migration, and EMT signature gene sets from hypoxia-induced directional migration. The
zero-order network consists of seed genes that have direct interaction without intermediate nodes. (C)
KEGG pathway analysis on the minimum interaction PPI network for hypoxia induced-directional
migration. Y-axis shows the enrichment p-value. The numbers above the bar plot represent the
number of hits for each pathway. (D) Venn diagram showing the intersection for secretome-induced
hypoxia and radial migration signature sets. There are two common genes between the hypoxia and
migration signature gene sets. The heat map displays the expression of these two common genes in
radial migration compared with non-hypoxic, non-migratory tumors. (E) Minimum protein-protein
interaction (PPI) network combining the hypoxia and migration signature gene sets from secretome-
induced radial migration. The signature gene sets in radial migration do not have a zero-order
network. Instead, the minimum network has intermediate nodes necessary to connect the seed genes.
(F) KEGG pathway analysis on the minimum interaction PPI network for secretome induced-radial
migration. Y-axis shows the enrichment p-value. The numbers above the bar plot represent the
number of hits for each pathway.
3.7. Drivers of Directional and Radial Migration Are Associated with Poor Patient Survival
To evaluate whether the compiled signature profile showed any potential for survival
prognosis, we analyzed the Kaplan survival plots of genes in the tumor-intrinsic hypoxia,
hypoxia-induced EMT, directional migration, and radial migration signatures (Figure 7).
Five genes from the tumor-intrinsic hypoxia signature set (CXCR4, FOXO3, LDHA, NDRG1,
NOS3), two genes each from the hypoxia-induced EMT (EFEMP2 and MGP), and 2 genes
from directional migration signatures (MAP3K3 and PIK3R3) were associated with poor
patient survival from the TCGA—breast carcinoma dataset (Figure 7A).
Indeed, histological images from Human Protein Atlas revealed overexpression of
these proteins in breast carcinoma patients compared to healthy tissue. A similar analysis
for the hypoxia and radial migration signature genes indicated that two genes from hypoxia
signature (ATM and KCNMA1), and four genes from radial migration signatures (KLF4,
EFNA1, IFITM1, and TGFBR1) were associated with poor patient survival (Figure 7B).
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Figure 7. Modulators of collective migration in large and small migratory tumors 
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Figure 7. Modulators of migration in large and small migratory tumors are associated with low
survival rate and prognosis: Kaplan survival plots and histological images from Human Protein
Atlas of ductal carcinoma and normal breast tissue of significant genes in (A) the hypoxia, EMT, and
migration signature sets from directional migration, and (B) hypoxia and migration signature sets
from radial migration. Kaplan plots show high expression in red and low expression in green.
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4. Discussion
Collective cell migration is a key feature of transition of ductal carcinoma in situ (DCIS)
to invasive ductal carcinoma (IDC), yet the microenvironmental factors and the underlying
mechanisms that trigger collective migration remain poorly understood. It has been widely
shown that growing solid tumors develop intrinsic hypoxia due to the limited diffusion of
nutrients and oxygen through the solid cell mass, causing changes in signaling pathways
that further lead to the emergence of aggressive migratory phenotypes [21]. Hypoxia
can also lead to secreted factors that can act as extrinsic signaling, further reshaping
the microenvironment and inducing phenotypic changes. In this study, we used three-
dimensional (3D) microtumor models to investigate gene expression changes observed in
distinct modes of collective migration in response to two different microenvironmental
factors, tumor-intrinsic hypoxia, and tumor-secreted factors (secretome).
In our discrete-sized microtumor models, we can generate large (600 µm) microtumors
that exhibit tumor-intrinsic hypoxia and directional migration without any external stimu-
lus, while small (150 µm) non-hypoxic microtumors exhibit radial migration only when
exposed to secretome of large hypoxic microtumors [17]. To investigate genomic differences
between hypoxia- and secretome-induced directional vs. radial migration modes, we ana-
lyzed differential gene expression profiles of hypoxia- and secretome-induced migratory
microtumors using non-hypoxic, non-migratory small microtumors as controls.
The statistical enrichment of large tumors with directional migratory phenotype
showed that the DEGs are principally related to hypoxia and the upregulation of hypoxia-
regulated downstream events, such as inflammatory response and EMT. The statistical
enrichment for the small non-hypoxic tumors with secretome-induced radial migratory
phenotype indicated that the DEGs are associated with response to extracellular stimulus,
inflammatory response, and TNFα singling.
GSEA analysis demonstrated that ‘hallmark hypoxia’ was upregulated and was the
most enriched gene set in directionally migrating microtumors. On the contrary, ‘hallmark
hypoxia’ was not enriched in the radially migrating small microtumors. In CE statistical
enrichment, both directional and radial migratory tumors have overlapping genes with GO
biological process ‘response to hypoxia’. However, the number of genes, significance, and
ratio of overlap was considerably higher in directional migratory phenotype. We conjecture
that even though the radially migrating microtumors do not develop hypoxia, the treatment
with the secretome from large hypoxic microtumors may contain cytokines/chemokines
secreted in response to hypoxia, which in turn can induce genomic changes that fall under
the GO term ‘response to hypoxia’. Our previous results show that inhibition of hypoxia
in directionally migrating tumors was more effective only when HIF-1α is inhibited at
early stages, and that inhibition of tumor-secreted factors such as soluble E-cadherin (sE-
CAD) and matrix metalloproteinases (MMPs) at any timepoint was effective in halting
tumor migration [17]. These prior results demonstrated that intrinsic hypoxia initiates the
directional migratory phenotype, which is subsequently maintained by tumor-secreted
factors in a feedback loop [17].
A further GSEA analysis demonstrated that ‘hallmark Epithelial to mesenchymal
transition (EMT)’ was uniquely enriched in the directional migration, but not in the radial
migration, suggesting that EMT may not be required in radial migration. Consistent with
the bioinformatic analysis, we earlier reported the upregulation of mesenchymal markers
such as vimentin (VIM) and fibronectin (FN) without loss of epithelial marker E-CAD in
directionally migrating tumors, suggesting the presence of a transient/partial EMT [17].
Moreover, we found increased levels of sE-CAD, FN, and MMP9 in the secretome of
directionally migrating tumors [17], indicating that intrinsic hypoxic environment triggers
directional migration and induces higher levels of tumor-secreted factors through the
acquisition of mesenchymal features. Supporting our prior results, our microarray analysis
confirmed that treatment of tumor-secreted factors from the large, hypoxic, directional
migratory tumors induce genomic changes in the non-hypoxic small tumors to initiate
migration in a radial fashion. Overall, enrichment of hallmark hypoxia, hallmark EMT,
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and migration terms from GSEA and CE analysis in large microtumors suggests interplay
between tumor-intrinsic hypoxia and EMT to induce directional migration. In contrast,
only migration term from GSEA and CE analysis was enriched in the secretome-induced
migratory phenotype, suggesting that tumor-secreted factors present in the hypoxic CM are
sufficient to induce radial migration in non-hypoxic tumors and EMT may not be always
required for emergence of migratory phenotypes.
From our gene expression analysis, we propose unique gene signatures that are
directly related to tumor-intrinsic hypoxia (79-gene hypoxia signature), hypoxia-induced
EMT (26-gene EMT signature), 69-gene directional migration signature, and 21-gene radial
migration signature. PPI network analysis of the tumor-intrinsic hypoxia, hypoxia-induced
EMT, and directional migratory genes revealed that these signature gene sets were highly
connected in the directional migratory tumors. However, there was no direct connection
or PPI between the genes associated with the hypoxia and radial migration signature
genes in the secretome-induced radial migratory phenotype. Interestingly, however, KEGG
enrichment analysis of the minimum and first-order interaction PPI networks revealed
mostly the same pathways enriched in both, directional and radial migratory phenotypes
although genes participating in each pathway are either different or if common, they are
oppositely regulated (downregulated or upregulated). This further suggests that the two
migratory phenotypes (directional and radial) emerge from differential regulations or
crosstalk between signaling molecules, activating different downstream mechanisms.
We used a meta-analysis to compare our genomic data with seven publicly available
studies that analyzed the effect of hypoxia in the gene expression of breast cancer cell lines
or breast cancer tissue. We found that the enrichment of the term ‘response to hypoxia’ in
the studies GSE3893, GSE19123, GSE29406, GSE70805, and GSE47533 is comparable to the
enrichment in our data, indicating a similar genomic profile in terms of hypoxia signature
in these studies. The enrichment of the terms ‘EMT’ and ‘regulation of cell migration’
in the study GSE29406 was comparable to the ones obtained for our data. This further
suggests a similar genomic profile of our data in terms of EMT and migration markers
with the ones in the study GSE29406. We have also found similarity of the results with
the ones obtained by El Guerrab et al., where the authors investigated the prognostic
value of hypoxia-related gene expression in breast cancer, using a comparative analysis
of hypoxia markers according to clinicopathological data [60]. Similar to our study, the
authors found upregulation of the hypoxia-related genes ENO1, FOXO3, VEGF, LDH, and
NPRG1 in recurrent patients with high grade breast cancer tumors [60]. In the work of Nair
et al., the authors built and validated individual predictors of breast cancer proliferation
and migration levels from the transcriptomics of 40 breast cancer cell lines [61]. Then,
the authors applied these predictors to estimate the proliferation and migration levels of
more than 1000 TCGA breast cancer tumors. The results of this study demonstrated that
predicted tumor migration levels are significantly more strongly associated with patient
survival than the proliferation levels. This study also found migration enhancer genes such
as FOSL2 and NFIL3, which are present in our signature gene sets [61]. KEGG analysis
of the migration enhancer genes indicated that ‘HIF-1 signaling pathway’ is the most
enriched pathway in the migration enhancer genes, which is consistent with our results
(Figure 6) [61]. Chen et al. used a microfluidic migration platform and single-cell RNA
sequencing to investigate gene expression profiles among three migratory breast cancer
cell lines and patient-derived cells [62]. Similar to our findings, the authors revealed
that migratory cells exhibited signatures of EMT and that depending on the migratory
phenotype, this EMT signature can vary. However, a common denominator was the
upregulation of the ‘HIF-1-alpha transcription factor network signaling pathway’. The
authors found overlapping DEGs in migratory cells as compared to non-migratory cells
in all three cell lines. These genes included TIMP1, HMGB1, ENO1, SDC2, and PLOD2,
which are also confirmed in our signature sets. These prior results further validate our
results and highlight the clinical relevance of our proposed gene signature sets.
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Survival analysis from DEGs on hypoxia-induced directional migration and secretome-
induced radial migration revealed that drivers of both directional and radial migration are
associated with poor survival rates in IDC patients. This indicates that individual factors
in the tumor microenvironment play a key role in promoting tumor aggressiveness and
hence, poor clinical outcomes.
Our results highlight the phenotypic heterogeneity and plasticity of collective mi-
gration under hypoxia and secretome as two different microenvironmental triggers of
migration using 3D cultures generated from the same T47D cell line. We also show as-
sociation between microenvironment-related unique gene signatures observed in our 3D
models and poor patient survival, demonstrating the importance of each tumor microenvi-
ronmental factor in the emergence of aggressive migratory phenotypes.
5. Conclusions
Using engineered 3D models of breast cancer, we can recapitulate two distinct (direc-
tional vs. radial) modes of collective migration induced by different microenvironmental
factors solely defined by microtumor size (tumor-intrinsic hypoxia) and tumor secretome.
To the best of our knowledge, this is a unique experimental approach that allows us to recre-
ate microenvironmental events such hypoxia and secretome, without external manipulation
of oxygen gradients or chemical factors. Bioinformatic analysis of our microarray data
suggests that directional migration is related with an interplay between tumor-intrinsic hy-
poxia and EMT. Interestingly, our analysis also suggests that tumor-secreted factors present
in the hypoxic microenvironment are sufficient to induce radial migration in non-hypoxic
tumors, and EMT may not be always required for emergence of all migratory phenotypes.
From statistical enrichment analysis, we obtained unique gene signatures related with
each tumor-intrinsic hypoxia-induced directional migration and secretome-induced ra-
dial migration. These unique gene signatures are associated with poor clinical outcomes,
demonstrating potential as a survival prognosis tool. Our work highlights the importance
of tumor microenvironment in the emergence of distinct migratory phenotypes as well as
the phenotypic and genotypic heterogeneity of collective migration.
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